Promising Advances in Stem Cell and Drug Therapies for Type 1 Diabetes
TL;DR Summary
A study presented at the American Diabetes Association's meeting shows that an off-the-shelf stem cell therapy called zimislecel enabled 10 out of 12 participants with type 1 diabetes to produce their own insulin and maintain healthy blood glucose levels for at least a year, with no severe hypoglycemia episodes reported after three months.
Topics:business#clinical-trial#health#insulin-production#stem-cell-therapy#type-1-diabetes#vertex-pharmaceuticals
- Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results STAT
- People With Severe Diabetes Are Cured in Small Trial of New Drug The New York Times
- London woman off insulin for Type 1 diabetes after a single dose of experimental manufactured stem cells CTV News
- Vertex’s Islet Cell Therapy VX-880 Restores Endogenous Insulin Secretion in Type 1 Diabetes CGTLive®
- Vertex at ADA 85th Scientific Sessions: Promising Diabetes Breakthrough Investing.com
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
1 min
vs 2 min read
Condensed
77%
226 → 53 words
Want the full story? Read the original article
Read on STAT